FREE NEJM E-TOC    HOME   |   SUBSCRIBE   |   CURRENT ISSUE   |   PAST ISSUES   |   COLLECTIONS   |   Search Term  Advanced Search

Sign in | Get NEJM's E-Mail Table of Contents — Free | Subscribe

Previous Volume 344:1553-1556 May 17, 2001 Number 20 Next

	Since this article has no abstract, we have provided an extract of the first 100 words of the full text and any section headings.

	Full Text PDF Purchase this article Add to Personal Archive Add to Citation Manager Notify a Friend E-mail When Cited

To the Editor: The findings of the Lung Health Study Research Group (Dec. 28 issue)¹ with regard to bone density should be interpreted with caution. The participants in the triamcinolone group had a nonsignificant 0.35 percent decrease in lumbar bone density between base line and 36 months, whereas there was a 0.98 percent increase in lumbar bone density in the participants in the placebo group. The increase is rather difficult to explain and would not be expected in patients in this age group. Moreover, this increase was not mirrored in the femoral neck, where there was a concomitant 0.22 percent . . . [Full Text of this Article]

References

HOME  |  SUBSCRIBE  |  SEARCH  |  CURRENT ISSUE  |  PAST ISSUES  |  COLLECTIONS  |  PRIVACY  |  HELP  |  beta.nejm.org Comments and questions? Please contact us. The New England Journal of Medicine is owned, published, and copyrighted © 2008 Massachusetts Medical Society. All rights reserved.